Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Non-Muscle Invasive Bladder Neoplasms × apaziquone × Clear all

Phase

Phase 3 3 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1

Interventions

apaziquone 1 Mitomycin 1 Interferon-alpha 1 BCG Vaccine 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01475266 2017-03-29

Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

Nippon Kayaku Co., Ltd.

Phase 2/3 Terminated

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡